Aggressive Ciliary Body Adenocarcinoma with Bilateral Lung Metastases: Histological, Molecular, Genetic and Clinical Aspects.
Ciliary body adenocarcinoma
Evisceration
Exenteration
Lung metastasis
Journal
Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
06
12
2017
revised:
13
02
2018
entrez:
13
4
2019
pubmed:
13
4
2019
medline:
13
4
2019
Statut:
ppublish
Résumé
To describe the clinical and histopathological features of an aggressive ciliary body adenocarcinoma with pulmonary metastases and skull base spread. A 45-year-old female patient presented with a post-traumatic phthisical eye that was eviscerated. This showed an unexpected carcinoma (positive for cytokeratins and melanocytic markers), the histological differential diagnosis for which included a primary ciliary body adenocarcinoma or a metastasis. The patient developed rapid post-surgical localized recurrence that required an orbital exenteration. This showed identical tumour to the evisceration specimen, with vascular invasion in orbital blood vessels and a contaminated orbital soft tissue margin. Staging imaging revealed multiple lung metastases, which were biopsied and shown to be a disseminated ciliary body adenocarcinoma rather than a disseminated primary lung carcinoma. The tumour spread locally to the skull base for which radiotherapy was given. Unfortunately, the patient passed away a few weeks later. To our knowledge, this is the first case of ciliary body adenocarcinoma with bilateral lung metastases. The malignant potential of these tumours should be considered as a possibility, and appropriate screening and staging tests should therefore be considered to guide appropriate management.
Identifiants
pubmed: 30976584
doi: 10.1159/000487805
pii: oop-0005-0079
pmc: PMC6422130
doi:
Types de publication
Journal Article
Langues
eng
Pagination
79-84Références
Am J Ophthalmol. 2002 Sep;134(3):445-7
pubmed: 12208262
Eur J Ophthalmol. 2002 Jul-Aug;12(4):319-23
pubmed: 12220004
Ophthalmologe. 2003 Aug;100(8):618-22
pubmed: 12955442
Arch Ophthalmol. 2009 Feb;127(2):141-5
pubmed: 19204229
J Med Case Rep. 2010 Jun 19;4:185
pubmed: 20565905
Genes Chromosomes Cancer. 1990 Sep;2(3):205-9
pubmed: 2078511
Ophthalmic Plast Reconstr Surg. 2012 Sep-Oct;28(5):331-4
pubmed: 22965012
PLoS One. 2012;7(11):e50415
pubmed: 23209738
Case Rep Ophthalmol Med. 2013;2013:786378
pubmed: 23607017
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3460-6
pubmed: 26030101
Can J Ophthalmol. 2016 Apr;51(2):e67-70
pubmed: 27085283
J Fr Ophtalmol. 2017 Feb;40(2):93-101
pubmed: 28126270
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5445-5451
pubmed: 29059311
Arch Ophthalmol. 1968 Aug;80(2):217-9
pubmed: 5661889
Int Ophthalmol Clin. 1980 Summer;20(2):177-90
pubmed: 6995386
Ophthalmology. 1996 Dec;103(12):2007-16
pubmed: 9003334
Ophthalmology. 1997 Aug;104(8):1265-76
pubmed: 9261313
J Hepatol. 1998 Jun;28(6):1058-63
pubmed: 9672184
Ophthalmology. 1999 Jan;106(1):103-10
pubmed: 9917789